Evidence map›Paper›PMID 34212239›Full record

ReviewPflugers Archiv : European journal of physiology2021

Cav1.4 dysfunction and congenital stationary night blindness type 2.

Alexandra Koschak, Monica L Fernandez-Quintero, Thomas Heigl, Marco Ruzza, Hartwig Seitter, Lucia Zanetti

Open access · hybridAbstract readReview
In one paragraph

Review in Pflugers Archiv : European journal of physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Impact of CaInternational journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Aland Island Eye Disease with Retinoschisis in the Clinical Spectrum ofInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Ribbon Synapses and Retinal Disease: Review.International journal of molecular sciences · 2023
    Review
  14. Review
  15. Review
  16. Review
  17. CaFrontiers in cell and developmental biology · 2023
    Article
  18. Photoreceptor Ion Channels in Signaling and Disease.Advances in experimental medicine and biology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Alexandra KoschakInstitute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria. alexandra.koschak@uibk.ac.at.ORCID 0000-0001-5758-1166
Monica L Fernandez-QuinteroInstitute of General, Inorganic and Theoretical Chemistry, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria.ORCID 0000-0002-6811-6283
Thomas HeiglInstitute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria.ORCID 0000-0003-1571-8579
Marco RuzzaInstitute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria.
Hartwig SeitterInstitute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria.ORCID 0000-0003-2100-4193
Lucia ZanettiInstitute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria.
Universität Innsbruck · AT

Funding

Austrian Science Fund FWF DOC 30Austrian Science Fund FWF P 32747
6 · The paper itself

Abstract

Cav1.4 L-type Ca

Indexed as

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterAnimalsCalcium Channel AgonistsCalcium Channels, L-TypeEye Diseases, HereditaryGenetic Diseases, X-LinkedHumansMutationMyopiaNight BlindnessRetinaSynapses3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterCACNA1F protein, humanCalcium Channel AgonistsCalcium Channels, L-TypeCalcium channelCav1.4Channel modulationChannelopathyCongenital stationary night blindness type 2Retinal disease

Identifiers

PMID34212239
PMCPMC8370969
OpenAlexW3176209760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.